Mircette

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2004
024619982004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
This randomized, double-blind, placebo-controlled exploratory study examined the efficacy and safety of a low-dose oral… (More)
Is this relevant?
2000
2000
One common side-effect of contraceptive use is that it often leads to disrupted endometrial bleeding patterns. This may be due to… (More)
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
1999
1999
Estrogen content represents a tradeoff between cycle control and side effects, but few direct comparisons of 20 and 30/35… (More)
Is this relevant?
1999
1999
Contraceptive use often leads to disrupted endometrial bleeding patterns in women. In this study, two different contraceptive… (More)
  • table I
  • table I
  • figure 1
  • figure 2
Is this relevant?
1998
1998
OBJECTIVE The purpose was to evaluate the metabolic effects of Mircette (brand of desogestrel/ethinyl estradiol and ethinyl… (More)
Is this relevant?
1998
1998
OBJECTIVE We assessed the effect of low ethinyl estradiol doses given during the nominally hormone-free interval of the Mircette… (More)
Is this relevant?
1998
1998
  • American journal of obstetrics and gynecology
  • 1998
OBJECTIVE The primary efficacy and safety of Mircette (brand of desogestrel/ethinyl estradiol and ethinyl estradiol), an oral… (More)
Is this relevant?
1998
1998
  • Contraceptive technology update
  • 1998
The new low-dose oral contraceptive (OC), Mircette, is the first pill to shorten the hormone-free interval. The dosing regimen… (More)
Is this relevant?
1998
1998
  • Contraceptive technology update
  • 1998
Another low-dose oral contraceptive (OC), Levlite, has received US Food and Drug Administration approval. Levlite, manufactured… (More)
Is this relevant?
1998
1998
  • Leon Speroff
  • American journal of obstetrics and gynecology
  • 1998
 
Is this relevant?